Skip to content
HowShorted

How shorted is Ginkgo Bioworks Holdings, Inc.? DNA

#595most shorted US stockof 3,805 ranked stocks, more shorted than 84%

10.64%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.45
5 reports (~10 weeks)
+2.74
days to cover
7.20
Aggregate net short position time series for Ginkgo Bioworks Holdings, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Ginkgo Bioworks Holdings, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
5 Aug 20267.90% 31 Jul 20268.31% 14 Aug 2026+0.41
7 May 20268.01% 30 Apr 20266.93% 15 May 2026−1.08
26 Feb 202611.98% 13 Feb 202612.09% 27 Feb 2026+0.11
6 Nov 202511.83% 31 Oct 202511.62% 14 Nov 2025−0.21
7 Aug 202513.94% 31 Jul 202512.00% 15 Aug 2025−1.94
6 May 202519.87% 30 Apr 202519.64% 15 May 2025−0.23
25 Feb 202515.23% 14 Feb 202515.62% 28 Feb 2025+0.39
12 Nov 202412.75% 31 Oct 202412.73% 15 Nov 2024−0.02

Fails to deliver

The SEC's fails-to-deliver figure for DNA: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
204
11 Sep 2026
Highest in window
136,016
6 Feb 2026
Days with a balance
87
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Ginkgo Bioworks Holdings, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 136K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2022 · 2023 · 2024 · 2025 · 2026

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202610.64%+0.45
31 Aug 202610.19%+1.88
14 Aug 20268.31%+0.41
31 Jul 20267.90%−0.07
15 Jul 20267.97%+0.07
30 Jun 20267.90%+0.39
15 Jun 20267.51%+0.53
29 May 20266.98%+0.05
15 May 20266.93%−1.08
30 Apr 20268.01%−1.84
15 Apr 20269.85%−0.08
31 Mar 20269.93%−3.00
13 Mar 202612.93%+0.84
27 Feb 202612.09%+0.11
13 Feb 202611.98%+0.93
30 Jan 202611.05%−0.55
15 Jan 202611.60%+0.59
31 Dec 202511.01%+0.29
15 Dec 202510.72%−0.22
28 Nov 202510.94%−0.68
14 Nov 202511.62%−0.21
31 Oct 202511.83%+0.59
15 Oct 202511.24%+1.37
30 Sep 20259.87%−0.73
15 Sep 202510.60%−0.73
29 Aug 202511.33%−0.67
15 Aug 202512.00%−1.94
31 Jul 202513.94%−3.73
15 Jul 202517.67%−2.87
30 Jun 202520.54%+1.21
13 Jun 202519.33%−0.86
30 May 202520.19%+0.55
15 May 202519.64%−0.23
30 Apr 202519.87%−3.12
15 Apr 202522.99%+3.35
31 Mar 202519.64%+2.45
14 Mar 202517.19%+1.57
28 Feb 202515.62%+0.39
14 Feb 202515.23%+0.87
31 Jan 202514.36%+0.74
15 Jan 202513.62%+0.79
31 Dec 202412.83%+0.35
13 Dec 202412.48%−0.42
29 Nov 202412.90%+0.17
15 Nov 202412.73%−0.02
31 Oct 202412.75%+5.85
15 Aug 20246.90%+1.32
31 Jul 20245.58%+1.18
15 Jul 20244.40%−1.08
28 Jun 20245.48%−5.29
14 Jun 202410.77%−0.33
31 May 202411.10%−1.31
15 May 202412.41%−1.05
30 Apr 202413.46%+1.08
15 Apr 202412.38%−0.20
28 Mar 202412.58%+0.40
15 Mar 202412.18%+0.30
29 Feb 202411.88%+0.07
15 Feb 202411.81%+0.63
31 Jan 202411.18%+0.14
12 Jan 202411.04%−0.08
29 Dec 202311.12%−0.17
15 Dec 202311.29%+0.41
30 Nov 202310.88%+0.36
15 Nov 202310.52%−0.62
31 Oct 202311.14%−0.52
13 Oct 202311.66%−0.14
29 Sep 202311.80%−0.05
15 Sep 202311.85%+1.38
31 Aug 202310.47%+0.04
15 Aug 202310.43%−0.41
31 Jul 202310.84%+0.40
14 Jul 202310.44%−0.25
30 Jun 202310.69%+1.82
15 Jun 20238.87%+0.08
31 May 20238.79%−0.91
15 May 20239.70%+0.07
28 Apr 20239.63%−0.45
14 Apr 202310.08%+0.21
31 Mar 20239.87%+1.00
15 Mar 20238.87%+1.34
28 Feb 20237.53%+1.08
15 Feb 20236.45%+0.08
31 Jan 20236.37%−0.10
13 Jan 20236.47%−0.04
30 Dec 20226.51%+0.62
15 Dec 20225.89%−0.22
30 Nov 20226.11%−0.30
15 Nov 20226.41%−1.11
31 Oct 20227.52%−1.24
14 Oct 20228.76%−0.84
30 Sep 20229.60%−0.91
15 Sep 202210.51%+0.48
31 Aug 202210.03%+1.95
15 Aug 20228.08%−0.38
29 Jul 20228.46%+0.32
15 Jul 20228.14%+0.57
30 Jun 20227.57%+1.38
15 Jun 20226.19%−1.06
31 May 20227.25%+1.16
13 May 20226.09%−0.20
29 Apr 20226.29%+0.77
14 Apr 20225.52%+0.48
31 Mar 20225.04%−0.92
15 Mar 20225.96%+0.16
28 Feb 20225.80%+0.09
15 Feb 20225.71%−0.58
31 Jan 20226.29%+1.46
14 Jan 20224.83%+1.11
31 Dec 20213.72%+0.83
15 Dec 20212.89%+1.72
30 Nov 20211.17%−0.09
15 Nov 20211.26%–

Newest first. Scroll inside the table for earlier dates, back to 15 Nov 2021.

Frequently asked questions

How shorted is Ginkgo Bioworks Holdings, Inc. right now?
10.64% of Ginkgo Bioworks Holdings, Inc.'s (DNA) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 595th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this DNA's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is DNA's days to cover?
7.20 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.